600
Participants
Start Date
September 14, 2020
Primary Completion Date
May 31, 2024
Study Completion Date
May 31, 2024
Lucentis (ranibizumab)
Lucentis® 0.5 mg via intravitreal injection once monthly
LUBT010 (proposed ranibizumab biosimilar)
LUBT010 (proposed ranibizumab biosimilar) 0.5 mg via intravitreal injection once monthly
Dr. Shroff's Charity Eye Hospital, New Delhi
Sir Ganga Ram Hosptial, New Delhi
Aakash Healthcare Super Specialty Hospital, New Delhi
Advanced Eye Centre Post Graduate Institute of Medical Education & Research, Chandigarh
Dr. J L Rohatgi Memorial Eye Hospital, Kanpur
R.K.Netralaya Eye Hospital (P) Ltd., Varanasi
King George's Medical University, Lucknow
Rising Retina Clinic, Ahmedabad
Government Eye Hospital M & J Institute of Ophthalmology, Ahmedabad
Kanoria Hospital and Research Center, Gandhinagar
Shivam Retina Clinic and Eye Hospital, Surat
Kiran Hospital Multi Super Speciality Hospital & Research Centre, Surat
Aditya Jyot Eye Hospital Pvt. Ltd., Mumbai
Shroff Eye Hospital & Vision Research Centre, Mumbai
Anideep Eye Hospital, Mumbai
Topiwala National Medical College & B. Y. L. Nair Charitable Hospital, Mumbai
Vijay Vallabh Hospital and Medical Research Center, Pālghar
Insight Institute of Ophthalmology, Pune
Dhadiwal Hospital in Coalition with Shreeji Healthcare, Nashik
Kamalnayan Bajaj Hospital, Aurangabad
Nethra Eye Hospital, Bangalore
Mysore Medical College and Research Institute, Mysore
JSS Hospital, Mysore
Regional Institute of Ophthalmology, Kolkata
The Eye Care Center, Guwahati
Kashyap Memorial Eye Hospital Pvt. Ltd., Ranchi
Lupin Ltd.
INDUSTRY